Collaborative Efforts for Brighter Vision, Ushering in a New Era of Ophthalmology From October 19 to 21, 2024, the “128th Annual Meeting of the American Academy of Ophthalmology (AAO 2024)” was grandly held in Chicago, USA. This prestigious event brought together elite scholars and industry experts from the global ophthalmology field, witnessing a brilliant convergence of international ophthalmic exchange in this city blending classic charm with modern innovation.
During the conference, experts and scholars engaged in extensive discussions on future trends in ophthalmology, enhancing professional skills and knowledge among ophthalmologists and researchers. The congress also emphasized the importance of eye health, raising public awareness of ophthalmic diseases and fostering societal attention and investment in eye care. It made comprehensive contributions to global ophthalmology development, patient care, and public health.
At the venue, BigVision Medical showcased its smart ophthalmic devices, including fully automated AI OCT, dry eye detectors, vision screeners, and more. The exhibits captivated doctors and clients from Italy, Brazil, the Netherlands, the USA, Australia, Canada, Mexico, Japan, Singapore, and other nations, who stopped by for in-depth experiences.
An Italian client praised BigVision’s medical devices, exclaiming, “This is exactly the product and solution portfolio I’ve been looking for!” A Brazilian client visited the booth daily for three consecutive days, demonstrating keen interest and enthusiasm.
Notably, a renowned professor from Maryland, USA, highly commended BigVision’s ophthalmic AI technology, recognizing its significant innovation and potential in eye care. This endorsement further highlighted BigVision’s expertise and forward-looking vision in AI ophthalmology.
BigVision’s showcase not only demonstrated China’s latest research achievements in AI ophthalmology but also embodied the practical application of “AI healthcare” in this field. Foreign experts and peers acknowledged that these innovative devices would enhance diagnostic accuracy and efficiency while promoting equitable distribution of ophthalmic resources, enabling high-quality care for patients in remote areas.
BigVision’s fully automated AI OCT simplifies operations with automated pupil alignment, focusing, and voice-guided instructions for self-administered within two minutes. Its user-friendly design empowers healthcare workers at all levels, alleviating resource strain. Integrated with advanced AI diagnostics, the device captures subtle retinal lesions in real time, aiding early detection of blinding conditions like diabetic retinopathy and age-related macular degeneration.
The dry eye detector combines intelligent precision, user-friendly operation, convenient reporting, and long-term tracking. Utilizing a large Placido ring scheme, it ensures comprehensive examination of tear film breakup and other metrics. Its fully automated workflow provides one-stop analysis of seven key indicators, including tear meniscus height, tear film breakup time, meibomian glands, eyelid margins, ocular redness, lipid layer quality, and corneal staining. Advanced AI-driven analysis assists doctors in formulating personalized treatment plans swiftly.
Portable, efficient, and accurate, the vision screener extends professional eye care to schools, communities, and remote regions. In pediatric vision protection, it identifies developmental anomalies such as myopia, hyperopia, and astigmatism, enabling timely intervention to prevent further deterioration.
With the successful conclusion of the 128th AAO Annual Meeting, the global ophthalmology community embarked on a new chapter of innovation and collaboration. BigVision’s remarkable presence at the event was not only an overseas showcase of China’s ophthalmic technology but also a vivid demonstration of the “AI+ophthalmology” concept transcending borders.
Looking ahead, BigVision Medical is advancing onto the global stage with unprecedented momentum, injecting new vitality into ophthalmic care worldwide. The company is actively introducing its full line of AI devices to international markets—from the world’s first AI OCT to vision screeners, dry eye detectors, biometric instruments, and the upcoming fully automated ultra-widefield fundus camera. BigVision is committed to delivering premium eye care services to every corner of the globe.
BigVision Healthcare leverages globally leading ophthalmic AI diagnostic technology and a suite of intelligent ophthalmic devices to address the urgent need for early detection and timely treatment of eye diseases worldwide, particularly in underdeveloped regions. By translating its corporate mission into action—”to promptly identify every pair of eyes at risk and deliver optimal care solutions”—the company is dedicated to advancing global eye care standards through technological innovation.
No comments yet.